Search

5 groups of experts have issued a joint statement urging the Parliament and Commission to adopt a new approach to RDI policy.

As the Industry, Research and Energy Committee reforms, Science|Business talks to Maria da Graça Carvalho about the committee’s new priorities.

Within five years 90 per cent of jobs across Europe will require computing skills, making ICT education a critical priority, says a new study.

Half way through its ten-year plan, the UK government claims to be making “good progress” in creating the right conditions for the knowledge-based economy.

The reshuffling of EU portfolios brings ‘innovation’ to the policy fore – but we are waiting for details (if they exist) of how it will all work, write Richard L. Hudson and Nuala Moran.

For the first time, innovation and entrepreneurship feature in job titles as the European Commission is remodelled.

As the Spanish government prepares to take on the EU Presidency, proposed cuts to its national R&D budget could undermine the EU’s innovation rhetoric.

Two thirds of private sector productivity growth in the UK between 2000 and 2007 was driven by innovation, according to a new Innovation Index.

Leading names in science and ethics are calling for a rethink in attitudes to the commercialisation of scientific knowledge.

Monica Beltrametti, Xerox’s R&D chief in Europe, asks whether recession can provide a stimulus to trans-Atlantic cooperation in research.

The UK’s Wellcome Trust has announced a major new scheme to give world class researchers seven-year grants to pursue individual research projects without constraints.

The European Investment Bank (EIB) and Pirelli have signed a €100 million finance contract to fund R&D projects by the Pirelli group from 2009 to 2012.

EU institutions need a common analysis of long-term trends as basis for policy, says MEP James Elles in an interview with Science|Business.

Six groups from Dutch and British universities go through to the ACES 2009 finals in Paris on 10 December.

Orthomimetics, founded by 2008 ACES winner Andrew Lynn, has been acquired by TiGenix, which plans to become a leader in regenerative medicine.